Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-omics identification of high responders to selexipag in pulmonary arterial hypertension
jRCT1010260038Active, not recruiting
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of selexipag in pulmonary arterial hypertension (PAH) (2 arms), sponsored by none. Primary endpoints: Whole-exome sequencing pathogenic variant differences, Whole-genome sequencing pathogenic variant differences and 2 more. Started Jul 2023; status: active, not recruiting.
02
Drugs
selexipag
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on jRCT1010260038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1010260038.